Search Results - "Caracta, C."

P142 Fluticasone propionate and fluticasone propionate/salmeterol delivered via multidose dry powder inhalers for persistent asthma by Raphael, G, Yiu, G, Sakov, A, Liu, S, Caracta, C

Get full text

P148 Long-term safety of fluticasone propionate and fluticasone propionate/salmeterol multidose dry powder inhalers in asthmatic patients by Mansfield, L, Yiu, G, Sakov, A, Liu, S, Caracta, C

Get full text

P139 Fluticasone propionate and fluticasone/salmeterol multidose dry powder inhalers compared with placebo for persistent asthma by Sher, L, Yiu, G, Sakov, A, Liu, S, Caracta, C

Get full text

P149 Fluticasone propionate and fluticasone propionate/salmeterol multidose dry powder inhaler pharmacokinetics in patients with persistent asthma by Ratner, P, Yiu, G, Nugent, C, Song, S, Caracta, C

Get full text

A randomised, placebo- and active-controlled dose-finding study of aclidinium bromide administered twice a day in COPD patients by Singh, D, Magnussen, H, Kirsten, A, Mindt, S, Caracta, C, Seoane, B, Jarreta, D, Garcia Gil, E

“…Abstract This Phase IIb, double-blind, double-dummy, placebo- and active-comparator-controlled crossover study ( ClinicalTrials.gov identifier: NCT01120093)…”
Get full text

Safety and pharmacokinetics of multiple doses of aclidinium bromide administered twice daily in healthy volunteers by Lasseter, K, Dilzer, S, Jansat, J.M, Garcia Gil, E, Caracta, C.F, Ortiz, S

“…Abstract Chronic obstructive pulmonary disease (COPD) is characterized by progressive airway obstruction and increased cholinergic tone. The Global Initiative…”
Get full text

Corrigendum to “A randomised, placebo- and active-controlled dose-finding study of aclidinium bromide administered twice a day in COPD patients” [Pulm Pharmacol Ther 25 (3) (2012) 248–253] by Singh, D, Magnussen, H, Kirsten, A, Mindt, S, Caracta, C, Seoane, B, Jarreta, D, Garcia Gil, E

Get full text

SEASONAL ALLERGIC RHINITIS NASAL SYMPTOM AND QUALITY OF LIFE IMPROVEMENTS WITH OLOPATADINE/MOMETASONE COMBINATION NASAL SPRAY by Gross, G., Berman, G., Amar, N., Caracta, C., Tantry, S.

“…Seasonal allergic rhinitis (SAR) symptoms often impair quality of life (QoL). In two randomized, double-blind phase 3 studies, twice-daily GSP301 nasal spray,…”
Get full text

LONG-TERM SAFETY AND EFFICACY OF OLOPATADINE/MOMETASONE COMBINATION NASAL SPRAY IN PATIENTS WITH PERENNIAL ALLERGIC RHINITIS by Segall, N., Lumry, W., Prenner, B., Caracta, C., Tantry, S.

“…The efficacy and safety of GSP301 nasal spray, a newly developed investigational fixed-dose combination of olopatadine hydrochloride/mometasone furoate, was…”
Get full text

P434 Efficacy and safety of olopatadine/mometasone combination nasal spray for the treatment of seasonal allergic rhinitis by Ratner, P., Hampel, F., Breazna, A., Caracta, C., Tantry, S.

Get full text

Fevers, weight loss, and bilateral peripheral infiltrates in a young man by Lee, F E, Caracta, C F, Fine, A, Berk, J L

Get more information

A32 NEW ASTHMA THERAPIES: CLINICAL STUDIES: Efficacy And Safety Of Formoterol Fumarate Via Pressair® Versus Foradil® Aerolizer® In Patients With Mild To Moderate Asthma by Bernstein, J A, Miller, D, Hampel, F, Zhong, X, D'Andrea, C, Caracta, C

Get full text

D44 COPD: TREATMENT FROM BRONCHODILATORS TO OTHER PHARMACOLOGICAL INTERVENTIONS: Efficacy Of Fixed-Dose Combination Aclidinium Bromide/formoterol Fumarate On Bronchodilation Over 1 Year: Augment COPD Extension Trial In Patients With Moderate To Severe COPD by D'Urzo, A D, Rennard, S I, Kerwin, E M, He, T, Leselbaum, A, Caracta, C

Get full text

D44 COPD: TREATMENT FROM BRONCHODILATORS TO OTHER PHARMACOLOGICAL INTERVENTIONS: Fixed-Dose Combination Of Aclidinium Bromide/formoterol Fumarate Improve Breathlessness And Health Status In COPD Patients: Augment COPD Trial by Rennard, S I, D'Urzo, A D, Jones, P W, Mergel, V, Leselbaum, A, Caracta, C

Get full text

D44 COPD: TREATMENT FROM BRONCHODILATORS TO OTHER PHARMACOLOGICAL INTERVENTIONS: Evaluation Of Major Adverse Cardiovascular Events And COPD Exacerbations In A Long-Term Study Of Aclidinium Bromide In Patients With Moderate To Very Severe COPD: Ascent COPD Rationale And Design by Wise, R A, Rekeda, L, D'Andrea, C, Shrestha, P, Caracta, C

Get full text

D44 COPD: TREATMENT FROM BRONCHODILATORS TO OTHER PHARMACOLOGICAL INTERVENTIONS: Lung Function And Safety Of Aclidinium Bromide/formoterol Fumarate Fixed-Dose Combination: Results Of A 1-Year Trial In Patients With COPD by Make, B J, Donohue, J F, Soong, W, Zhong, X, Leselbaum, A, Caracta, C

Get full text

B104 IT'S NO LONGER A SECRET SERVICE: UPDATES IN COPD PHARMACOTHERAPY: Twice-Daily Aclidinium Bromide/formoterol Fumarate Fixed-Dose Combination: Lung Function Improvements In The Augment COPD Trial In Patients With Moderate To Severe COPD by D'Urzo, A D, Rennard, S I, Kerwin, E M, Mergel, V, Leselbaum, A, Caracta, C

Get full text

D44 COPD: TREATMENT FROM BRONCHODILATORS TO OTHER PHARMACOLOGICAL INTERVENTIONS: Cardiovascular Safety Of Fixed-Dose Combination Aclidinium Bromide/formoterol Fumarate: Results Of Two 6-Month Studies In Patients With Moderate To Severe COPD by Donohue, J F, D'Urzo, A D, Singh, D, Mergel, V, Molins, E, Shrestha, P, Leselbaum, A, Caracta, C

Get full text

B104 IT'S NO LONGER A SECRET SERVICE: UPDATES IN COPD PHARMACOTHERAPY: The Effect Of Aclidinium/formoterol Fixed-Dose Combination On COPD Symptoms And Health Status In Patients With COPD: Results From The Acliform/COPD Study by Jones, P W, Singh, D, Bateman, E D, Korn, S, Serra, C, Molins, E, Caracta, C, Leselbaum, A

Get full text

D44 COPD: TREATMENT FROM BRONCHODILATORS TO OTHER PHARMACOLOGICAL INTERVENTIONS: Long-Term Safety Of Fixed-Dose Combination Aclidinium Bromide/formoterol Fumarate In Patients With Moderate To Severe COPD: The Augment COPD Extension Trial by Rennard, S I, D'Urzo, A D, Donohue, J F, He, T, Shrestha, P, Leselbaum, A, Caracta, C

Get full text